The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Endo International PLC

Nasdaq: ENDP
Last

(U.S.) $7.57

Today's change+0.30 +4.13%
Updated November 21 4:00 PM EST. Delayed by at least 15 minutes.
 

Endo International PLC

Nasdaq: ENDP
Last

(U.S.) $7.57

Today's change+0.30 +4.13%
Updated November 21 4:00 PM EST. Delayed by at least 15 minutes.

Endo International PLC up sharply

Endo International PLC closed up sharply Tuesday, rallying (U.S.)$0.30 or 4.13% to (U.S.)$7.57. Over the last five days, shares have gained 8.30%, but are down 54.04% for the last year to date. Shares have underperformed the S&P 500 by 73.97% during the last year.

Key company metrics

  • Open(U.S.) $7.30
  • Previous close(U.S.) $7.27
  • High(U.S.) $7.60
  • Low(U.S.) $7.30
  • Bid / Ask(U.S.) $7.43 / (U.S.) $7.54
  • YTD % change-54.04%
  • Volume4,354,944
  • Average volume (10-day)7,840,844
  • Average volume (1-month)7,851,265
  • Average volume (3-month)6,660,134
  • 52-week range(U.S.) $5.77 to (U.S.) $17.99
  • Beta0.50
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forward2.06×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$19.26
Updated November 21 4:00 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
-108.95%

Endo International PLC has a net profit margin of -108.95%. Besides being negative, it is also below the industry average and implies that this company is not effective at turning revenues into bottom line profit.
Company Books

S&P TSX0.45%Sector:HealthcareIndustry:Pharmaceuticals - Generic & Specialty

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2017Q2/2017Q1/2017Q4/2016
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201709/30/2017Jun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016
Revenue7878761,0381,242
Total other revenue--------
Total revenue7878761,0381,242
Gross profit272336369485
Total cost of revenue515539669757
Total operating expense7891,5141,1054,536
Selling / general / administrative136156177213
Research & development40414346
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)997782163,521
Other operating expenses, total--------
Operating income-2-638-67-3,295
Interest income (expense), net non-operating-129-123-113-113
Gain (loss) on sale of assets--------
Other--------
Income before tax-128-754-177-3,406
Income after tax-100-696-165-3,333
Income tax, total-28-57-12-72
Net income-97-1,397-174-3,338
Total adjustments to net income--------
Net income before extra. items-100-696-165-3,333
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-100-696-165-3,333
Inc. avail. to common incl. extra. items-97-1,397-174-3,338
Diluted net income-97-1,397-174-3,338
Dilution adjustment--------
Diluted weighted average shares223223223223
Diluted EPS excluding extraordinary itemsvalue per share-0.45-3.12-0.74-14.96
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share0.08-0.78-0.05-4.58